Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 0.1 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr) - canis lupus familiaris hair 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - chaetomium globosum (unii: 5016wb8b8a) (chaetomium globosum - unii:5016wb8b8a) - chaetomium globosum 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - pea (unii: w4x7h8gyfm) (pea - unii:w4x7h8gyfm) - pea 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3) - ambrosia artemisiifolia pollen 100000 [au] in 1 ml - indications and usage     allergenic extract is indicated for diagnostic testing and treatment (immunotherapy) of patients whose histories indicate allergic symptoms upon natural exposure to short ragweed pollen.  confirmation is determined by skin testing. contraindications     do not administer in the presence of diseases characterized by bleeding diathesis.  individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization.  recent myocardial infarction patients may not tolerate immunotherapy.  children with nephrotic syndrome probably should not receive injections due to a possibility of immunization causing exacerbation of their nephrotic disease.     standardized short ragweed extract is not intended for the treatment of patients who do not experience allergic symptoms upon natural exposure to the allergen.     allergenic extracts are not intended for diagnosing patients whose skin does not manifest immediate hypersensitiv

Stati Uniti - inglese - NLM (National Library of Medicine)

antigen laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml - indications and usage     allergenic extract is indicated for diagnostic testing and treatment (immunotherapy) of patients whose histories indicate allergic symptoms upon natural exposure to grass allergens. confirmation is determined by skin testing. 10,000 bau/ml extracts are intended for percutaneous testing. if negative, 100,000 bau/ml products can be used for percutaneous test. dilutions made from 10,000 bau/ml products are indicated for immunotherapy of previously untreated patients. if 10,000 bau/ml product is tolerated and symptoms persist, dilutions made from 100,000 bau/ml can be administered. standardized grass pollen extracts labeled in bioequivalent allergy units (bau/ml) are not interchangeable with grass pollen extracts labeled in allergy units (au/ml) or with non-standardized grass pollen extracts. contraindications     do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of underly

Australia - inglese - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - apraclonidine hydrochloride -

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

clinect nz pty limited - apraclonidine hydrochloride 5.75 mg/ml equivalent to 5 mg apraclonidine - eye drops, solution - 0.5 % - active: apraclonidine hydrochloride 5.75 mg/ml equivalent to 5 mg apraclonidine excipient: benzalkonium chloride hydrochloric acid purified water sodium acetate trihydrate sodium chloride sodium hydroxide - iopidine eye drops 0.5% are indicated for short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional intraocular pressure reduction. patients on maximally tolerated medical therapy who are treated with iopidine eye drops 0.5% to delay surgery should have frequent follow up examinations and treatment should be discontinued if the intraocular pressure rises significantly.

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

generics (uk) limited - atenolol, chlortalidone - coated tablets - 100/25 milligram - beta blocking agents, selective, and other diuretics